Asian markets ended mostly higher on Tuesday, tracking a Wall Street rally overnight after the United States Food and Drug Administration granted full approval for the Pfizer-BioNTech corona-virus vaccine, while global investors are awaiting the US Federal Reserve's annual Jackson Hole conference later in the week for hints at when it may taper its monetary stimulus. Chinese shares gained after reports that the US Securities and Exchange Commission has begun issuing new disclosure requirements to Chinese companies that want to list in New York, part of an effort to boost investor awareness of the risks involved. Further, Japanese shares ended higher with hopes for a faster economic recovery globally.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,514.47 | 37.34 | 1.07 |
Hang Seng | 25,727.92 | 618.33 | 2.46 |
Jakarta Composite | 6,089.50 | -20.33 | -0.33 |
KLSE Composite | 1,553.37 | 30.94 | 2.03 |
Nikkei 225 | 27,732.10 | 237.86 | 0.87 |
Straits Times | 3,107.62 | 20.06 | 0.65 |
KOSPI Composite | 3,138.30 | 48.09 | 1.56 |
Taiwan Weighted | 16,818.73 | 76.89 | 0.46 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: